Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study
暂无分享,去创建一个
B. Gutiérrez | J. L. D. Luna del Castillo | J. Cervilla | José Gutiérrez-Fernández | Sara Mañanes-González | J. Carrillo-Ávila | A. Sorlózano-Puerto
[1] J. Lucas,et al. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice , 2014, European Neuropsychopharmacology.
[2] S. Leucht,et al. Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia. , 2014, The Cochrane database of systematic reviews.
[3] Xiaobai Li,et al. Effects of prenatal chronic mild stress exposure on hippocampal cell proliferation, expression of GSK-3α, β and NR2B in adult offspring during fear extinction in rats , 2014, International Journal of Developmental Neuroscience.
[4] Yong-Ku Kim,et al. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[5] F. Dickerson,et al. Exposure to herpes simplex virus, type 1 and reduced cognitive function. , 2013, Journal of psychiatric research.
[6] D. Inta,et al. Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[7] K. Hashimoto,et al. Prenatal immune activation and subsequent peripubertal stress as a new model of schizophrenia , 2013, Expert review of neurotherapeutics.
[8] R. Yolken,et al. Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial. , 2013, Schizophrenia bulletin.
[9] D. Inta,et al. The differential effects of acute vs. chronic stress and their combination on hippocampal parvalbumin and inducible heat shock protein 70 expression , 2013, Neuroscience.
[10] F. Bruschi,et al. Toxoplasmosis and neuropsychiatric diseases: can serological studies establish a clear relationship? , 2013, Neurological Sciences.
[11] J. Feldon,et al. Stress in Puberty Unmasks Latent Neuropathological Consequences of Prenatal Immune Activation in Mice , 2013, Science.
[12] G. McConkey,et al. Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour? , 2013, Journal of Experimental Biology.
[13] F. Dickerson,et al. Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. , 2012, Schizophrenia bulletin.
[14] L. Klei,et al. Persistent infection with neurotropic herpes viruses and cognitive impairment , 2012, Psychological Medicine.
[15] R. Yolken,et al. Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring—a matched case–control study , 2012, Schizophrenia Research.
[16] B. Gutiérrez,et al. Infectious agents associated with schizophrenia: A meta-analysis , 2012, Schizophrenia Research.
[17] Dennis Velakoulis,et al. Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis , 2012, Schizophrenia Research.
[18] F. Dickerson,et al. Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia , 2012, Schizophrenia Research.
[19] D. Kelly,et al. Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms , 2011, Schizophrenia Research.
[20] T. Werge,et al. Association of GRIN1 and GRIN2A‐D With schizophrenia and genetic interaction with maternal herpes simplex virus‐2 infection affecting disease risk , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[21] J. Marín,et al. Estandarización y validación clínica de la prueba de reacción en cadena de la polimerasa (PCR) para diagnóstico de toxoplasmosis cerebral en pacientes infectados por el VIH , 2011 .
[22] J. Dubey,et al. The Neurotropic Parasite Toxoplasma Gondii Increases Dopamine Metabolism , 2011, PloS one.
[23] T. Lerman-Sagie,et al. Prenatal brain imaging in congenital toxoplasmosis , 2011, Prenatal diagnosis.
[24] R. Yolken,et al. Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. , 2011, The American journal of psychiatry.
[25] P. Mortensen,et al. Toxoplasma infection and later development of schizophrenia in mothers. , 2011, The American journal of psychiatry.
[26] R. Wank,et al. Increased prevalence of Chlamydophila DNA in post-mortem brain frontal cortex from patients with schizophrenia , 2011, Schizophrenia Research.
[27] R. Yolken,et al. Antibodies to infectious agents and the positive symptom dimension of subclinical psychosis: The TRAILS study , 2011, Schizophrenia Research.
[28] M. Regulska,et al. Prenatal lipopolysaccharide treatment enhances MK-801-induced psychotomimetic effects in rats , 2011, Pharmacology Biochemistry and Behavior.
[29] Terry L. Jernigan,et al. The Basics of Brain Development , 2010, Neuropsychology Review.
[30] M. Pittler. Systematic Reviews in Health Care: Meta‐analysis in Context , 2010 .
[31] F. Dickerson,et al. Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia , 2010, Schizophrenia Research.
[32] B. Czéh,et al. Stress Impairs GABAergic Network Function in the Hippocampus by Activating Nongenomic Glucocorticoid Receptors and Affecting the Integrity of the Parvalbumin-Expressing Neuronal Network , 2010, Neuropsychopharmacology.
[33] Enrico Fainardi,et al. Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders , 2010, Interdisciplinary perspectives on infectious diseases.
[34] F. Dickerson,et al. Toxoplasma and schizophrenia , 2009, Parasite immunology.
[35] Tyrone D. Cannon,et al. Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring. , 2009, Microbes and infection.
[36] D. Inta,et al. Differential c-Fos induction by different NMDA receptor antagonists with antidepressant efficacy: potential clinical implications. , 2009, The international journal of neuropsychopharmacology.
[37] J. Gutiérrez,et al. Chlamydophila pneumoniae: desde su proteómica hasta la arteriosclerosis , 2008 .
[38] A. Aker,et al. The schizophrenia and Toxoplasma gondii connection: Infectious, immune or both? , 2008, Advances in therapy.
[39] P. Boksa. Maternal infection during pregnancy and schizophrenia. , 2008, Journal of psychiatry & neuroscience : JPN.
[40] Douglas G. Altman,et al. Systematic reviews in health care : meta-analysis in context , 2008 .
[41] R. Yolken,et al. Results From a Hypothesis Generating Case-Control Study: Herpes Family Viruses and Schizophrenia Among Military Personnel , 2007, Schizophrenia bulletin.
[42] R. Yolken,et al. Antibodies to Infectious Agents in Individuals at Ultra-High Risk for Psychosis , 2007, Biological Psychiatry.
[43] Yasuhiro Suzuki,et al. Effects of Toxoplasma gondii infection on the brain. , 2007, Schizophrenia bulletin.
[44] R. Yolken,et al. Early infections of Toxoplasma gondii and the later development of schizophrenia. , 2007, Schizophrenia bulletin.
[45] O. Geçici,et al. Anti-Toxoplasma gondii antibodies in patients with schizophrenia--preliminary findings in a Turkish sample. , 2007, Schizophrenia bulletin.
[46] F. Dickerson,et al. Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality. , 2007, Schizophrenia bulletin.
[47] R. Yolken,et al. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. , 2007, Schizophrenia bulletin.
[48] J. Flegr. Effects of toxoplasma on human behavior. , 2007, Schizophrenia bulletin.
[49] D. Hinze‐Selch,et al. A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. , 2007, Schizophrenia bulletin.
[50] R. Yolken,et al. Editors' Introduction: Schizophrenia and Toxoplasmosis , 2007 .
[51] R. Yolken,et al. Toxoplasma gondii as a Risk Factor for Early-Onset Schizophrenia: Analysis of Filter Paper Blood Samples Obtained at Birth , 2007, Biological Psychiatry.
[52] R. Wank,et al. Associations between Chlamydophila infections, schizophrenia and risk of HLA-A10 , 2007, Molecular Psychiatry.
[53] O. Liesenfeld,et al. Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city , 2006, BMC infectious diseases.
[54] Hui-ling Wang,et al. Prevalence of Toxoplasma infection in first‐episode schizophrenia and comparison between Toxoplasma‐seropositive and Toxoplasma‐seronegative schizophrenia , 2006, Acta psychiatrica Scandinavica.
[55] Alan S. Brown,et al. Prenatal infection as a risk factor for schizophrenia. , 2006, Schizophrenia bulletin.
[56] Charles P Quesenberry,et al. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. , 2005, The American journal of psychiatry.
[57] R. Yolken,et al. Antibodies to infectious agents in individuals with recent onset schizophrenia , 2004, European Archives of Psychiatry and Clinical Neuroscience.
[58] R. Yolken,et al. Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients , 2003, Schizophrenia Research.
[59] R. Kahn,et al. Schizophrenia after prenatal exposure to Toxoplasma gondii? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] J. Gutiérrez,et al. ELISA test to detect Chlamydophila pneumoniae IgG , 2002, Journal of basic microbiology.
[61] R. Yolken,et al. Maternal infections and subsequent psychosis among offspring. , 2001, Archives of general psychiatry.
[62] J. M. Rubio,et al. Genotypic Characterization of Toxoplasma gondii Strains Associated with Human Toxoplasmosis in Spain: Direct Analysis from Clinical Samples , 2001, Journal of Clinical Microbiology.
[63] R. Yolken,et al. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[64] P. Coyle,et al. Description of a Nonlethal Herpes Simplex Virus Type 1 Glycoprotein D Deletion Mutant Affecting a Site Frequently Used for PCR , 2000, Clinical Diagnostic Laboratory Immunology.
[65] R. Fukuda,et al. No Changes in Paired Viral Antibody Titers during the Course of Acute Schizophrenia , 1999, Neuropsychobiology.
[66] M. Isohanni,et al. Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort. , 1998, The American journal of psychiatry.
[67] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[68] Y. Ohtsuki,et al. Human herpesvirus 6 (HHV-6)-positive Burkitt's lymphoma: establishment of a novel cell line infected with HHV-6. , 1997, Blood.
[69] C. Begg,et al. Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.
[70] T. Kawayama,et al. [Detection of Chlamydia pneumoniae by polymerase chain reaction]. , 1993, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.
[71] M. Casanova,et al. Search for evidence of herpes simplex virus, type 1, or varicella‐zoster virus infection in postmortem brain tissue from schizophrenic patients , 1992, Acta psychiatrica Scandinavica.
[72] T. Crow,et al. Search for viral nucleic acid sequences in the post mortem brains of patients with schizophrenia and individuals who have committed suicide. , 1987, Journal of neurology, neurosurgery, and psychiatry.
[73] L. DeLisi,et al. Herpes simplex virus, cytomegalovirus and Epstein–Barr virus antibody titres in sera from schizophrenic patients , 1986, Psychological Medicine.
[74] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[75] T. Crow,et al. Viruses in human brains: a search for cytomegalovirus and herpes virus 1 DNA in necropsy tissue from normal and neuropsychiatric cases , 1986, Psychological Medicine.
[76] J. Stevens,et al. A search for cytomegalovirus and herpes viral antigen in brains of schizophrenic patients. , 1984, Archives of general psychiatry.
[77] Stefan Leucht,et al. Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. , 2014, The Cochrane database of systematic reviews.
[78] A. Camacho,et al. [Chlamydophila pneumoniae: from its proteomics to arteriosclerosis]. , 2008, Enfermedades infecciosas y microbiologia clinica.
[79] D. Cowan,et al. Selected infectious agents and risk of schizophrenia among U.S. military personnel. , 2008, The American journal of psychiatry.
[80] W. Alexander. American psychiatric association. , 2008, P & T : a peer-reviewed journal for formulary management.
[81] R. Yolken,et al. Schizophrenia and toxoplasmosis. , 2007, Schizophrenia bulletin.
[82] R. Yolken,et al. Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia , 2007, Molecular Psychiatry.
[83] J. Zonis,et al. Antibodies to Epstein-Barr virus, herpes simplex type 1, cytomegalovirus and measles virus in psychiatric patients , 2005, Archives of Virology.
[84] R. Wank,et al. High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy. , 2005, Medical hypotheses.
[85] S. Mesa-Castillo. [An ultrastructural study of the temporal lobe and peripheral blood in schizophrenic patients]. , 2001, Revista de neurologia.
[86] J. Kleinman,et al. Search for viral nucleic acid sequences in brain tissues of patients with schizophrenia using nested polymerase chain reaction. , 1996, Archives of general psychiatry.
[87] Y. Ginot,et al. Herpes simplex virus and cytomegalovirus in the serum of schizophrenic patients versus other psychosis and normal controls. , 1992, The Israel journal of psychiatry and related sciences.